Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 31 results for "cadila healthcare"

Zydus subsidiary receives USFDA nod to market Tamiflu drug
Money Control

Zydus Cadila gets USFDA nod for antihistamine drug

Drug firm Zydus Cadila today said it has received approval from the US health regulator to market antihistamine Cyproheptadine Hydrochloride tablets in the US market. The company has received final approval from the United States Food and Drug Administration ... Business Standard, 21 hours ago

39 images for cadila healthcare

Money Control, 1 month ago
Money Control, 1 week ago
Money Control, 1 week ago
Money Control, 1 week ago
Money Control, 1 month ago
Money Control, 1 month ago
Business Standard, 2 months ago
Money Control, 2 months ago
Money Control, 2 months ago
Money Control, 3 months ago

Pharma stocks see heavy selling pressure, down up to 6%

Pharma stocks today witnessed heavy selling pressure, falling up to 6 per cent in an overall weak broader market. Shares of Aurobindo Pharma tumbled 5.94 per cent, Orchid Pharma tanked 5.57 per cent, Cipla went down by 4.89 per cent and Morepen Lab (4.76 per ...
 Business Standard17 hours ago

Global Stock Markets End on a Positive Note with Emerging Markets leading Gains

Posted by Equitymaster Global financial markets ended the week on a positive note with a boost from emerging markets. The share markets of Brazil, Hong Kong and Japan were up 3.8%, 2.8% and 2.2% respectively. However, share markets in United States and France ...
 Equitymaster.com1 week ago Global Markets Close the Week on a Mixed Note  Equitymaster.com2 months ago

USFDA completes inspection of Cadila's Changodar plant

Drug firm Cadila Healthcare today said the USFDA has completed inspection of its manufacturing plant at Changodar with "no observation".
 DNA1 month ago Cadila Healthcare moves up after facility clears USFDA inspection  Business Standard1 month ago Cadila's Topical manufacturing facility successfully completes USFDA inspection  Money Control1 month ago

Cadila Healthcare's Changodar plant gets no USFDA observation; shares rise

In February, the company's Moraiya unit too did not receive any observations from USFDA
 Business Standard1 month ago Cadila Healthcare gets 3 USFDA observations for Baddi plant  DNA2 months ago US regulator observations at Baddi unit may not effect Cadila  Business Standard2 months ago Cadila Healthcare gets Form 483 from USFDA; Stock recovers after sharp setback  Sify2 months ago

Cadila gets stakeholders' nod for scheme of arrangement

Drug firm Cadila Healthcare has received overwhelming approval from stakeholders for scheme of arrangement between the company and Zydus Healthcare Ltd. Almost 100 per cent shareholders have approved "the scheme of arrangement between Cadila Healthcare Ltd ...
 Business Standard1 month ago
Money Control

Sun Pharma, Cadila Healthcare recall products from US market

Sun Pharma and Cadila Healthcare are recalling one product each from the US market due to contamination and presence of "foreign" tablets respectively. While Sun Pharmaceutical Industries Inc is recalling 83,188 single dose vials of Testosterone Cypionate ...
 Business Standard1 month ago
Business Standard

Cadila Healthcare's Baddi unit receives 3 observations under Form 483

Observations, given by US FDA, are related to pre-approval inspection for a specific product filed March 2, 2017 Last Updated at 17:14 IST Following an inspection by the US Food & Drug Administration (FDA) from February 20, 2017 to March 1, 201, Cadila ...
 Business Standard2 months ago Cadila Healthcare falls 7% on US FDA observations at Baddi plant  Money Control2 months ago
Money Control

Cadila Healthcare Q3 PAT seen up 9.5% to Rs 369.6 cr: KR Choksey

Net Sales are expected to increase by 7.5 percent Q-o-Q (up 7.3 percent Y-o-Y) to Rs 2512.6 crore, according to KR Choksey.
 Money Control2 months ago
Money Control

Cadila inks pact with Supernus Pharma to settle patent issue

Cadila Healthcare today said that it has finalised a pact with Supernus Pharmaceuticals to settle patent litigation regarding Trokendi XR extended-release capsules, used for treatment of seizures. Cadila Healthcare, along with subsidiary Zydus Pharmaceuticals ...
 Business Standard2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less